Integrated Filing — IndAS



General information about company

Scrip Code 506235
NSE Symbol ALEMBICLTD
MSEI Symbol NOTLISTED
ISIN INE426A01027
Name of company Alembic Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 10-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 31-10-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 10-11-2025   16:00:00
End date and time of board meeting 10-11-2025   16:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 5,586.04 10,560.98
Other income 6,492.32 6,851.20
Total income 12,078.36 17,412.18
2 Expenses
(a) Cost of materials consumed 252.60 598.06
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 40.34 214.55
(d) Employee benefit expense 755.48 1,538.14
(e) Finance costs 56.41 115.74
(f) Depreciation, depletion and amortisation expense 281.68 560.87
(f) Other Expenses
1 Cost of Construction 1,290.76 2,300.72
2 Other Expenses 922.84 1,627.57
Total other expenses 2,213.60 3,928.29
Total expenses 3,600.11 6,955.65
3 Total profit before exceptional items and tax 8,478.25 10,456.53
4 Exceptional items 0.00 0.00
5 Total profit before tax 8,478.25 10,456.53
6 Tax expense
7 Current tax 1,105.37 1,306.90
8 Deferred tax (233.33) (236.11)
9 Total tax expenses 872.04 1,070.79
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 7,606.21 9,385.74
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 5,242.94 9,627.41
16 Total profit (loss) for period 12,849.15 19,013.15
17 Other comprehensive income net of taxes 12,596.75 13,041.30
18 Total Comprehensive Income for the period 25,445.90 32,054.45
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 12,849.16 19,013.17
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 25,445.91 32,054.47
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 5,135.64 5,135.64
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 5 7.4
Diluted earnings (loss) per share from continuing operations 5 7.4
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 5 7.4
Diluted earnings (loss) per share from continuing and discontinued operations 5 7.4
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above results have been reviewed by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company. 2. The previous quarter's / year's figures have been regrouped / rearranged wherever necessary to make it comparable with the current quarter / year. 3. Figures rounded off to the nearest decimal.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 13,456.47
Capital work-in-progress 21.75
Investment property 29,172.10
Goodwill 5.07
Other intangible assets 0.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 1,60,368.85
Non-current financial assets
Non-current investments 42,880.09
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets 810.95
Total non-current financial assets 43,691.04
Deferred tax assets (net) 0.00
Other non-current assets 3,500.00
Total non-current assets 2,50,215.28
2 Current assets
Inventories 9,203.17
Current financial asset
Current investments 8,245.60
Trade receivables, current 3,103.56
Cash and cash equivalents 140.53
Bank balance other than cash and cash equivalents 200.61
Loans, current 0.00
Other current financial assets 292.86
Total current financial assets 11,983.16
Current tax assets (net) 0.00
Other current assets 1,286.96
Total current assets 22,473.29
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,72,688.57
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 5,135.64
Other equity 2,48,444.42
Total equity attributable to owners of parent 2,53,580.06
Non controlling interest 0.00
Total equity 2,53,580.06
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 857.04
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 1,175.31
Total non-current financial liabilities 2,032.35
Provisions, non-current 325.90
Deferred tax liabilities (net) 4,747.17
Deferred government grants, Non-current 0.00
Other non-current liabilities 0.00
Total non-current liabilities 7,105.42
Current liabilities
Current financial liabilities
Borrowings, current 401.23
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 573.82
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 2,282.52
Total Trade payable 2,856.34
Other current financial liabilities 1,015.37
Total current financial liabilities 4,272.94
Other current liabilities 4,838.62
Provisions, current 2,160.84
Current tax liabilities (Net) 730.69
Deferred government grants, Current 0.00
Total current liabilities 12,003.09
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 19,108.51
Total equity and liabilites 2,72,688.57
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Active Pharmaceutical Ingredients Business 1,030.48 2,325.89
2 Real Estate Business 4,555.56 8,235.09
Total Segment Revenue 5,586.04 10,560.98
Less: Inter segment revenue 0.00 0.00
Revenue from operations 5,586.04 10,560.98
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Active Pharmaceutical Ingredients Business 195.06 467.99
2 Real Estate Business 2,041.36 3,635.04
Total Profit before tax 2,236.42 4,103.03
i. Finance cost 56.41 115.74
ii. Other Unallocable Expenditure net off Unallocable income (6,298.36) (6,469.25)
Profit before tax 8,478.37 10,456.54
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Active Pharmaceutical Ingredients Business 18,430.34 18,430.34
2 Real Estate Business 48,698.19 48,698.19
Total Segment Asset 67,128.53 67,128.53
Un-allocable Assets 2,05,560.04 2,05,560.04
Net Segment Asset 2,72,688.57 2,72,688.57
4 Segment Liabilities
Segment Liabilities
1 Active Pharmaceutical Ingredients Business 3,254.78 3,254.78
2 Real Estate Business 10,375.86 10,375.86
Total Segment Liabilities 13,630.64 13,630.64
Un-allocable Liabilities 5,477.86 5,477.86
Net Segment Liabilities 19,108.50 19,108.50
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Amount of items that will not be reclassified to profit and loss 1433434000 1481601000
Total Amount of items that will not be reclassified to profit and loss 14,334.34 14,816.01
2 Income tax relating to items that will not be reclassified to profit or loss 2,039.82 2,108.33
3 Amount of items that will be reclassified to profit and loss
1 Amount of items that will be reclassified to profit and loss 30223000 33362000
Total Amount of items that will be reclassified to profit and loss 302.23 333.62
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 12,596.75 13,041.30



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 10,456.53
Adjustments for reconcile profit (loss)
Adjustments for finance costs 115.74
Adjustments for decrease (increase) in inventories 735.53
Adjustments for decrease (increase) in trade receivables, current (106.60)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1.16)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 112.53
Adjustments for other financial assets, current 25.80
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 30.25
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 466.29
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 560.87
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (24.10)
Adjustments for provisions, non-current 81.77
Adjustments for other financial liabilities, current 191.71
Adjustments for other financial liabilities, non-current (71.27)
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 6,288.30
Adjustments for interest income 75.05
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (85.65)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (4,331.64)
Net cash flows from (used in) operations 6,124.89
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,106.16
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 5,018.73
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 9,035.44
Other cash payments to acquire equity or debt instruments of other entities 11,762.37
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 57.15
Proceeds from sales of investment property 0.00
Purchase of investment property 2,263.55
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 6,288.30
Interest received 75.05
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (34.74)
Net cash flows from (used in) investing activities 1,280.98
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 186.47
Payments of lease liabilities 0.00
Dividends paid 6,128.01
Interest paid 115.74
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (6,430.22)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (130.51)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (130.51)
Cash and cash equivalents cash flow statement at beginning of period 271.03
Cash and cash equivalents cash flow statement at end of period 140.52